These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38364435)

  • 1. Efficacy of Topical Dapsone 5% Gel for the Treatment of Erythematotelangiectatic Rosacea: New Treatment Option With Old Drug.
    Gökşin Ş; İmren IG; Kaçar N
    Dermatol Pract Concept; 2024 Jan; 14(1):. PubMed ID: 38364435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapsone Gel in the Treatment of Papulopustular Rosacea: A Double-Blind Randomized Clinical Trial.
    Faghihi G; Khosravani P; Nilforoushzadeh MA; Hosseini SM; Assaf F; Zeinali N; Smiley A
    J Drugs Dermatol; 2015 Jun; 14(6):602-6. PubMed ID: 26091386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world Evidence for the Treatment of Rosacea with Sulfur or Metronidazole Preparation in Japanese Patients.
    Nobeyama Y; Aihara Y; Asahina A
    JMA J; 2023 Oct; 6(4):448-454. PubMed ID: 37941711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal tranexamic acid microinjections: a novel treatment option for erythematotelangiectatic rosacea.
    Daadaa N; Litaiem N; Karray M; Bacha T; Jones M; Belajouza Noueiri C; Goucha S; Zeglaoui F
    J Cosmet Dermatol; 2021 Oct; 20(10):3324-3329. PubMed ID: 33973361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of intense pulsed light for treating erythematotelangiectatic rosacea is related to severity and age.
    Lim HS; Lee SC; Won YH; Lee JB
    Ann Dermatol; 2014 Aug; 26(4):491-5. PubMed ID: 25143679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Efficacy and Safety of Topical Dapsone Gel, 5% for the Treatment of Acne Vulgaris in Adult Females With Skin of Color.
    Alexis AF; Burgess C; Callender VD; Herzog JL; Roberts WE; Schweiger ES; Stockton TC; Gallagher CJ
    J Drugs Dermatol; 2016 Feb; 15(2):197-204. PubMed ID: 26885788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, controlled, split-face study of topical timolol maleate 0.5% eye drops for the treatment of erythematotelangiectatic rosacea.
    Wei D; Hamblin MR; Wen X
    J Cosmet Dermatol; 2021 Dec; 20(12):3968-3973. PubMed ID: 34333845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized Controlled Pilot Study: Combined 595-nm Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride Topical Cream Superior to Oxymetazoline Hydrochloride Cream for Erythematotelangiectatic Rosacea.
    Sodha P; Suggs A; Munavalli GS; Friedman PM
    Lasers Surg Med; 2021 Dec; 53(10):1307-1315. PubMed ID: 34233378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel azelaic acid formulation for the topical treatment of inflammatory rosacea: A multicentre, prospective clinical trial.
    Dall'Oglio F; Tedeschi A; Lacarrubba F; Fabbrocini G; Skroza N; Chiodini P; Micali G
    J Cosmet Dermatol; 2021 Apr; 20 Suppl 1(Suppl 1):28-31. PubMed ID: 33934475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Study of Factors Affecting Efficacy of Therapy with Dye Pulsed Light for Erythematotelangiectatic Rosacea.
    Zhao L; You C; Chen H; Wang J; Cao J; Qi M; Hou S; Zheng X; Shao L; Liu Q
    Dermatol Ther (Heidelb); 2020 Dec; 10(6):1273-1283. PubMed ID: 32865718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concerns and Treatment Satisfaction in Patients Being Treated With Azelaic Acid Foam for Rosacea.
    Williamson T; Cameron J; McLeod K; Turner B; Quillen A; LaRose A; Lott J; Gaiser A
    J Drugs Dermatol; 2019 Apr; 18(4):381-386. PubMed ID: 31013011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of erythematotelangiectatic rosacea with the fractionation of high-fluence, long-pulsed 595-nm pulsed dye laser.
    Baek JO; Hur H; Ryu HR; Kim JS; Lee KR; Kim YR; Choi KH
    J Cosmet Dermatol; 2017 Mar; 16(1):12-14. PubMed ID: 27762482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of permethrin 5% topical gel vs. placebo for rosacea: a double-blind randomized controlled clinical trial.
    Raoufinejad K; Mansouri P; Rajabi M; Naraghi Z; Jebraeili R
    J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2105-2117. PubMed ID: 27600257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for rosacea.
    van Zuuren EJ; Fedorowicz Z; Carter B; van der Linden MM; Charland L
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD003262. PubMed ID: 25919144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of non-surgical short-wave radiofrequency treatment of mild-to-moderate erythematotelangiectatic rosacea: a prospective, open-label pilot study.
    Wang B; Xie HF; Deng YX; Li J; Jian D
    Arch Dermatol Res; 2022 May; 314(4):341-347. PubMed ID: 33934172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of permethrin 2.5% with tea tree oil gel on rosacea treatment: A double-blind, controlled clinical trial.
    Ebneyamin E; Mansouri P; Rajabi M; Qomi M; Asgharian R; Azizian Z
    J Cosmet Dermatol; 2020 Jun; 19(6):1426-1431. PubMed ID: 31613050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 Trials.
    Thiboutot DM; Kircik L; McMichael A; Cook-Bolden FE; Tyring SK; Berk DR; Chang-Lin JE; Lin V; Kaoukhov A
    J Clin Aesthet Dermatol; 2016 Oct; 9(10):18-27. PubMed ID: 27847545
    [No Abstract]   [Full Text] [Related]  

  • 18. A Prospective Randomized Controlled Pilot Study to Assess the Response and Tolerability of Cold Atmospheric Plasma for Rosacea.
    Hofmeyer S; Weber F; Gerds S; Emmert S; Thiem A
    Skin Pharmacol Physiol; 2023; 36(4):205-213. PubMed ID: 37490882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior Efficacy with Ivermectin 1% Cream Compared to Metronidazole 0.75% Cream Contributes to a Better Quality of Life in Patients with Severe Papulopustular Rosacea: A Subanalysis of the Randomized, Investigator-Blinded ATTRACT Study.
    Schaller M; Dirschka T; Kemény L; Briantais P; Jacovella J
    Dermatol Ther (Heidelb); 2016 Sep; 6(3):427-36. PubMed ID: 27432169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of Life in Individuals with Erythematotelangiectatic and Papulopustular Rosacea: Findings From a Web-based Survey.
    Zeichner JA; Eichenfield LF; Feldman SR; Kasteler JS; Ferrusi IL
    J Clin Aesthet Dermatol; 2018 Feb; 11(2):47-52. PubMed ID: 29552276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.